Efficacy and safety of bevacizumab in Turkish patients with metastatic and recurrent cervical cancer.

Özlem Ercelep Deniz Tataroğlu Özyükseler Melike Ozcelik Heves Surmeli Mustafa Değirmenci Mevlüde İnanç Mehmet Aliustaoğlu Mahmut Gümüş

Published in: Turkish journal of obstetrics and gynecology (2020)

Adding bevacizumab to platinum and paclitaxel chemotherapy in a case of metastatic or recurrent cervical cancer is an effective and tolerable treatment for Turkish patients.

Keyphrases

end stage renal disease
ejection fraction
chronic kidney disease
newly diagnosed
squamous cell carcinoma
small cell lung cancer
prognostic factors
peritoneal dialysis
metastatic colorectal cancer
locally advanced
chemotherapy induced
patient reported